Weight loss drugs may help fight migraines

Date:

Share this article:

Del denne artikel:

Early research suggests GLP-1 drugs may reduce migraine symptoms in some patients.

Living with migraine often means putting everyday life on hold without warning. A severe attack can disrupt work, family plans, and even simple daily activities, making the search for better treatments a priority for millions of people.

According to research presented at the American Academy of Neurology's Annual Meeting and reported by Health, scientists are investigating whether GLP-1 medications, widely used to treat type 2 diabetes and obesity, could also play a role in migraine management. While the evidence remains preliminary, the findings have attracted growing attention, reports VeryWell Health.

Fewer severe migraine episodes

An observational study involving more than 20,000 adults with migraine compared several GLP-1 medications with topiramate, a commonly prescribed preventive treatment.

People taking GLP-1 drugs were less likely to require emergency department visits or hospitalization. However, researchers emphasize that the study found an association rather than proving that the medications directly prevent migraine attacks.

Also read: Experts say this viral skincare trend may actually have real benefits

More than weight loss

Scientists are also exploring why these medications may influence migraine symptoms. Smaller studies suggest some patients experienced fewer headaches even before significant weight loss occurred.

This has led researchers to investigate whether GLP-1 drugs may reduce inflammation or lower pressure around the brain, rather than relying solely on weight loss to improve symptoms.

More research is still needed

Experts caution that GLP-1 medications are not approved for migraine prevention, and current evidence is not strong enough to recommend them for off-label use. Larger placebo-controlled clinical trials are needed to confirm both their effectiveness and long-term safety.

Even so, researchers believe GLP-1 therapies could eventually become an important addition to migraine treatment, particularly for people who also live with obesity or other metabolic conditions.

Also read: Scientists discover unexpected brain activity in life's final moments

For now, the findings represent an encouraging step toward expanding future treatment options.

Also read: Researchers discover surprising link between stepping speed and longevity

This article is made and published by Mie Hermansen, who may have used AI in the preparation.

Other articles

Skin-to-skin contact is linked to a lower risk of death in premature babies, review finds

A large review of nearly 50 trials suggests the practice still isn't standard in many hospitals, and that may cost lives.

7 signs your body has been making too much cortisol – even when you think you’re coping

Many people live for years with raised cortisol without realizing it, and the warning signs look nothing like ordinary tiredness.

A common stroke drug may also slow joint damage

The drug has been used for years to prevent strokes, and animal tests now hint at a very different job for it.

Forget sleeping pills: This tiny patch could be the future of better sleep

The skin-worn device uses gentle sound waves to nudge the sleeping brain, and early tests hint at a calmer stress response too.

Skin-to-skin contact is linked to a lower risk of death in premature babies, review finds

A large review of nearly 50 trials suggests the practice still isn't standard in many hospitals, and that may cost lives.

7 signs your body has been making too much cortisol – even when you think you’re coping

Many people live for years with raised cortisol without realizing it, and the warning signs look nothing like ordinary tiredness.

A common stroke drug may also slow joint damage

The drug has been used for years to prevent strokes, and animal tests now hint at a very different job for it.